D7034ZZ
Beam Radiation Lymphatics, Neck to None with None, Heavy Particles (Protons,Ions) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | 7 Lymphatic and Hematologic System |
| Operation | 0 Beam Radiation |
| Body Part | 3 Lymphatics, Neck |
| Approach | 4 Heavy Particles (Protons,Ions) |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Beam radiation to the lymphatic and hematologic system delivers external radiation, typically from a linear accelerator, to lymph node regions or hematologic tissue affected by cancers such as Hodgkin lymphoma, non-Hodgkin lymphoma, or localized involvement from leukemia. Treatment is usually planned as a fractionated course given over several weeks, with the total dose divided into smaller daily sessions to maximize tumor control while allowing normal tissue to recover between treatments.
It is used both as primary therapy for certain lymphomas confined to specific nodal regions and as consolidation after chemotherapy to eliminate residual disease in previously bulky sites. Patients typically receive planning imaging beforehand to map the treatment field precisely to the involved nodal chain.
Anatomy & Axis Detail
Lymphatics, Neck
The cervical lymphatic chains drain the head, neck, oral cavity, and thyroid, and are frequently involved by lymphoma, head and neck squamous cell carcinoma, or thyroid malignancy, making them a common target for regional nodal irradiation. Beam radiation to the neck lymphatics is planned around numerous adjacent structures, including the spinal cord, salivary glands, larynx, and carotid vessels, so field design and shielding are critical to limit xerostomia, dysphagia, and long-term vascular injury. Treatment may address a single palpable nodal level or an entire nodal basin depending on disease extent and whether the approach is definitive or adjuvant to surgery. Documentation should identify the specific nodal levels or chains encompassed by the field, since this distinguishes limited from comprehensive neck irradiation.
Modality Qualifier: Heavy Particles (Protons,Ions)
Heavy Particles (Protons, Ions) covers particle-beam radiotherapy using protons or heavier charged ions, which exhibit a Bragg peak that concentrates dose at a specific depth with minimal exit dose beyond the target. This property distinguishes it from conventional photon or electron beams, which continue to deposit dose along their path, and makes heavy particle therapy attractive for tumors near critical structures like the spinal cord or optic pathways.
Coding & Documentation
Coders need documentation specifying the treatment site (a named lymph node region, spleen, or other hematologic structure), the modality as external beam, and the qualifier describing the type of beam, such as photon or electron therapy, drawn from the radiation oncology treatment plan and daily treatment records.
A common error is coding the diagnosis-driven anatomic site rather than the actual field treated, since radiation fields are often described in oncology shorthand like "mantle field" or "involved-site radiotherapy" that must be translated to the correct body part value. Failing to capture the correct qualifier for beam type is another frequent gap when the treatment summary isn't reviewed closely.